News >

Simon Says Immunotherapy Combo Regimens on Horizon in NSCLC

Danielle Bucco
Published: Monday, Dec 04, 2017

George R. Simon, MD
George R. Simon, MD
Immunotherapy continues to show single-agent efficacy in non–small cell lung cancer (NSCLC) and is now being investigated in combination regimens to further improve patient outcomes.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Online Medical Crossfire®: 5th Annual Miami Lung Cancer ConferenceMay 30, 20196.5
Community Practice Connections™: Practical Application of Sequencing for EGFR-Mutant Lung Cancers: A Focus on Recent Evidence and Key Next Steps in TrialsJun 29, 20192.5
Publication Bottom Border
Border Publication